Cato Corp
NYSE:CATO
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Cato Corp
Cash Equivalents
Cato Corp
Cash Equivalents Peer Comparison
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Cato Corp
NYSE:CATO
|
Cash Equivalents
$23.9m
|
CAGR 3-Years
11%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-11%
|
|
Burlington Stores Inc
NYSE:BURL
|
Cash Equivalents
$742.3m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
48%
|
CAGR 10-Years
27%
|
|
Abercrombie & Fitch Co
NYSE:ANF
|
Cash Equivalents
$864.2m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
TJX Companies Inc
NYSE:TJX
|
Cash Equivalents
$5.1B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
18%
|
CAGR 10-Years
9%
|
|
Gap Inc
NYSE:GPS
|
Cash Equivalents
$1.5B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
10%
|
CAGR 10-Years
0%
|
|
Ross Stores Inc
NASDAQ:ROST
|
Cash Equivalents
$4.9B
|
CAGR 3-Years
0%
|
CAGR 5-Years
28%
|
CAGR 10-Years
28%
|
See Also
What is Cato Corp's Cash Equivalents?
Cash Equivalents
23.9m
USD
Based on the financial report for Feb 3, 2024, Cato Corp's Cash Equivalents amounts to 23.9m USD.
What is Cato Corp's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
-11%
Over the last year, the Cash Equivalents growth was 20%. The average annual Cash Equivalents growth rates for Cato Corp have been 11% over the past three years , -1% over the past five years , and -11% over the past ten years .